Accelerated plasminogen activator dose regimens for coronary thrombolysis

This publication has 29 references indexed in Scilit:

• Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC patency study (TAPS)
  Journal of the American College of Cardiology, 1992
• Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.
  Circulation, 1991
• Enhancing thrombolytic efficacy by means of “front-loaded” administration of tissue plasminogen activator
  Journal of the American College of Cardiology, 1989
• Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1989
• A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.
  Circulation, 1989
• Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.
  Circulation, 1988
• A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Optimal Dosage Regimens of Tissue-Type Plasminogen Activator
  Seminars in Thrombosis and Hemostasis, 1987
• Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.
  Circulation, 1986
• The use of single plane angiocardiograms for the calculation of left ventricular volume in man
  American Heart Journal, 1968